Asper Nephrology

Published 29/08/2019

We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas. The new portfolio includes tests for common monogenic diseases, as well as complex disorders. To establish the genetic cause of renal diseases we use next-generation sequencing technology to accommodate a broad differential diagnosis. CNV analysis based on sequencing data is also available to enhance precise diagnosis. Visit https://www.asperbio.com/asper-nephrology/ to see the full list of tests.

CNV analysis

Published 13/08/2019

We have integrated copy number variation (CNV) detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and whole exome sequencing. 

View the complete list of all tests www.asperbio.com/genetic-tests/

Asper Cardiogenetics updates

Published 19/07/2019

We now offer an NGS panel for Hereditary Hemorrhagic Telangiectasia. Additionally, Noonan Syndrome test has been upgraded to Noonan Spectrum Disorders/Rasopathies test including several new disease-causing genes. All NGS panels in Asper Cardiogenetics testing menu are covered by CNV analysis based on sequencing data. Visit https://www.asperbio.com/asper-cardiogenetics/ to learn more.

Updated Asper Oncogenetics menu

Published 11/07/2019

We have updated our Asper Oncogenetics menu. Genetic testing for Prostate Cancer is now available. The testing includes sequencing of the panel of genes and CNV analysis. Other NGS panels in the Asper Oncogenetics menu now also include CNV analysis. View our updated pricelist at www.asperbio.com/Asper Oncogenetics

News in Asper Ophthalmics

Published 04/07/2019

We are pleased to announce that our NGS panels now include CNV analysis.

In addition, three new genes have been added to the Bardet-Biedl Syndrome panel.

Visit www.asperbio.com/asper-ophthalmics to learn more about our new testing options and see the updated price list.

Asper Dermatology

Published 21/01/2019

We are proud to announce a brand new testing menu – Asper Dermatology, which includes gene panels targeting the diagnostics of different skin related inherited disorders. New panels also facilitate differential diagnosis of diseases with overlapping features. Visit www.asperbio.com/asper-dermatology/ to find out more.

Updates in Asper Ophthalmics

Published 12/10/2018

Asper Ophthalmics testing menu has been updated with Senior-Loken Syndrome gene panel. We have also added a number of genes to Cone-Rod Dystrophy, Vitelliform Macular Dystrophy, and comprehensive eye diseases panels. Comprehensive eye diseases panel now covers 283 genes associated with different eye disorders. View updated testing options at www.asperbio.com/asper-ophthalmics/

Asper Biogene at EAN Congress 2018

Published 01/06/2018

We will be attending the 4th Congress of the European Academy of Neurology in Lisbon, 16-19 June. Do not miss the opportunity to get informed about recent developments and news in clinical neurology. Stop by the exhibition hall to learn about Asper Neurogenetics tests and get acquainted with our experts. Looking forward to meeting you at booth #C24!

Del/dup analysis

Published 21/03/2018

Del/dup analysis can now be ordered in addition to NGS panels. Read more about upgraded testing options at each portfolio or see the price list www.asperbio.com/Asper-Biogene-price-list. Feel free to contact us if there are any additional genes you would need to be included in the analysis.

Congenital Myopathy and Distal Myopathy NGS panel

Published 22/01/2018

Congenital Myopathy and Distal Myopathy NGS panel has been added to Asper Neurogenetics portfolio. The new panel includes analysis of 43 genes linked to numerous types of myopathy. Learn more about test www.asperbio.com/congenital-myopathy-and-distal-myopathy

We would be very grateful for any comments on whether this panel can enhance your testing activities or additional genes/conditions should be involved in the panel. Contact us at info[at]asperbio.com and give your feedback.

End-of-Year Price Reduction!

Published 21/11/2017

All our catalogue prices will be reduced by 10% for the next two months. Use the great opportunity and make sure  to place your order before January 31, 2018.

Asper Metabolic Disorders

Published 03/11/2017

Asper Biogene is pleased to introduce our new testing portfolio of metabolic disorders. Single gene tests as well as multigene panels are included in Asper Metabolic Disorders’ menu. Glycogen and lysosomal storage diseases, fatty acid oxidation disorders, and urea cycle disorders are represented among others.

Full list of tests is available on www.asperbio.com/asper-metabolic-disorders

New tests in Asper Cardiogenetics

Published 18/10/2017

We have expanded our selection of cardiovascular genetic tests to include tests for different types of dyslipidemias, cardiomyopathies, and arrhythmias.  In addition, pulmonary arterial hypertension test has been upgraded with a set of genes to facilitate differential diagnosis. Full list of tests is available: www.asperbio.com/asper-cardiogenetics/

Skeletal Ciliopathies

Published 05/10/2017

Asper Dysmorphology now includes NGS panel for the diagnostics of skeletal ciliopathies. The panel encompasses testing of different forms of short-rib thoracic dysplasia as well as phenotypically overlapping disorders like cranioectodermal dysplasias. For further information visit www.asperbio.com/skeletal-ciliopathies